In LC, characterized by an increased MEK5/ERK5 signaling axis phosphorylation, was recently demonstrated that pharmacological and genetic inhibition of both proteins reduced LC cell proliferation [39]. Here, MAP2K5 is linked to laryngotracheoesophageal cleft.